Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muzaffar H Qazilbash

Showing results (41-50 of 188) with videos related to

Pageof 19
Sort By:
Leukemia Research|June 19, 2014
Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasmsGuilin Tang, Sa A Wang, Victoria Lu, et al.
Journal of the National Cancer Institute|November 20, 2015
Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic ReviewYucai Wang, Fang Yang, Yan Shen, et al.
Transplantation and Cellular Therapy|January 20, 2024
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) TrialEhsan Malek, Jeries Kort, Leland Metheny, et al.
Cancers|December 9, 2023
Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma CellsGuilin Tang, Yilin Wu, Pei Lin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantationJonas A de Souza, Rima M Saliba, Poliana Patah, et al.
Leukemia & Lymphoma|October 26, 2011
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplantQaiser Bashir, Mark F Munsell, Sergio Giralt, et al.
Leukemia & Lymphoma|January 17, 2012
Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplantAmer M Beitinjaneh, Rima Saliba, Qaiser Bashir, et al.
Blood|December 2, 2006
Hyperacute GVHD: risk factors, outcomes, and clinical implicationsRima M Saliba, Marcos de Lima, Sergio Giralt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2015
Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and AmyloidosisNina Shah, Qiuling Shi, Loretta A Williams, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 18, 2013
Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantationNaveen Pemmaraju, Maria Florencia Tanaka, Farhad Ravandi, et al.
Pageof 19

Showing results (41-50 of 188) with videos related to

Sort By:
Pageof 19
Leukemia Research|June 19, 2014
Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasmsGuilin Tang, Sa A Wang, Victoria Lu, et al.
Journal of the National Cancer Institute|November 20, 2015
Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic ReviewYucai Wang, Fang Yang, Yan Shen, et al.
Transplantation and Cellular Therapy|January 20, 2024
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) TrialEhsan Malek, Jeries Kort, Leland Metheny, et al.
Cancers|December 9, 2023
Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma CellsGuilin Tang, Yilin Wu, Pei Lin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantationJonas A de Souza, Rima M Saliba, Poliana Patah, et al.
Leukemia & Lymphoma|October 26, 2011
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplantQaiser Bashir, Mark F Munsell, Sergio Giralt, et al.
Leukemia & Lymphoma|January 17, 2012
Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplantAmer M Beitinjaneh, Rima Saliba, Qaiser Bashir, et al.
Blood|December 2, 2006
Hyperacute GVHD: risk factors, outcomes, and clinical implicationsRima M Saliba, Marcos de Lima, Sergio Giralt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2015
Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and AmyloidosisNina Shah, Qiuling Shi, Loretta A Williams, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 18, 2013
Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantationNaveen Pemmaraju, Maria Florencia Tanaka, Farhad Ravandi, et al.
Pageof 19